Posts tagged “Biotech & Life Science”

May 10, 2007

Premium Lock BD Biosciences to Add 100 Jobs as Part of Durham Plant Expansion

BD Company says it will invest $25 million in manufacturing facility at Treyburn.

Updated May 10, 2007

Premium Lock Inspire Shares Take 10% Hit on Report of Increase in Losses

Inspire Upfront payment for recently approved eye drug helps drive up costs.

Updated May 8, 2007

Premium Lock Quintiles Forms Global Biologics Regulatory Team

Quintiles logo Group will work with customers seeking assistance in advancing biologic-based therapies.

May 3, 2007

Premium Lock CED Announces Biotech 2007 Lineup

CED The Council for Entrepreneurial Development on Thursday confirmed the lineup for the eight panel sessions at Biotech 2007.

May 2, 2007

Premium Lock Pozen Narrows Quarterly Loss

Pozen Pozen Inc. (NASDAQ: POZN) said Wednesday that it had a net loss of $2.1 million, or 7 cents per share, for the first quarter of 2007, compared to a net loss of $6.4 million, or 22 cents per share, a year ago.

Updated May 1, 2007

Premium Lock Inspire Wins FDA Approval for Eye Medication

inspire The U.S. Food and Drug Administration on Monday approved a conjunctivitis medication made by Inspire Pharmaceuticals Inc.

April 30, 2007

Premium Lock Fueling North Carolina’s Future: North Carolina’s Strategic Plan for Biofuels Leadership

CED Developing biofuels will set N.C. on a long-term transformation away from dependence on petroleum and into a more diverse energy economy with much stronger ties to agriculture and forestry.

April 26, 2007

Premium Lock BioDelivery Sciences Stock Soars 30% on Positive Drug Trial News

BDSI Triangle-based drug development firm reports effectiveness in use of breakthrough pain killer.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith